No products in the cart.
Dienogest Tablets 2mg × 28 Tablets (Changyining)
$2.00
Dienogest Tablets (Changyining) contain 2mg of dienogest per tablet, formulated for laboratory and preclinical research focused on hormonal modulation, endometriosis models, and reproductive pharmacology.
?? This product is strictly for research purposes only. Not for human, therapeutic, or diagnostic use.?Please consult staff for other specifications and uses?
Description
Dienogest Tablets Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Dienogest Tablets (Changyining) |
| Generic Name | Dienogest |
| CAS Number | 65928-58-7 |
| Molecular Formula | C??H??NO? |
| Molecular Weight | 311.42 g/mol |
| Dosage Form | Oral tablet |
| Strength | 2mg per tablet |
| Pack Size | 14 tablets × 2 blister packs per box (Total: 28 tablets) |
| Approval Number | H20249426 (China NMPA) |
| Product Code | 86983319000025 |
| Manufacturer | Wuhan Jiulong Renfu Pharmaceutical Co., Ltd. (Changyining Brand) |
| Barcode | 6972217290694 |
| Storage Conditions | Store in a cool, dry place below 25°C; protect from light and moisture |
| Intended Use | Laboratory research only |
Dienogest Tablets Mechanism of Action
Dienogest is a synthetic progestin with selective progestogenic activity. It acts primarily by:
Inhibiting gonadotropin secretion (FSH/LH)
Reducing estrogen stimulation in target tissues
Suppressing ovulation in experimental models
Commonly studied in endometriosis, estrogen-sensitive conditions, and contraceptive research.
Research Applications & Pharmacological Insights
Endometriosis Modeling: Evaluation of anti-estrogenic and anti-inflammatory effects
Hormonal Modulation Studies: Impact on the hypothalamic-pituitary-ovarian axis
Reproductive Endocrinology: Role in ovulation suppression and uterine remodeling
Cancer Research: Dienogest’s impact on hormone-sensitive tumor cells
Combination Drug Studies: Interaction with estrogen or GnRH analogs in lab models
Pharmacokinetics (For Research Purposes):
Absorption: Rapid and complete after oral administration
Half-life: ~9–10 hours
Metabolism: Hepatic (CYP3A4 pathway)
Excretion: Renal and fecal
Safety Profile & Handling
Safety Notes:
In vivo high-dose exposure may affect hormonal balance or liver enzymes
Use appropriate PPE when handling
Avoid exposure by inhalation or skin contact during preparation
Handling Recommendations:
Conduct procedures in a well-ventilated area or fume hood
Dispose of any waste in accordance with lab chemical safety regulations
Avoid contamination of other compounds during analytical or biological assays
?? Research Use Disclaimer
This product is intended exclusively for laboratory research. It is not to be used for therapeutic, diagnostic, clinical, or veterinary purposes. Improper handling may pose safety risks and invalidate experimental data.
Additional information
| Weight | 1.1 kg |
|---|---|
| Dimensions | 18 × 16 × 18 cm |
Q1: Can Changyining Dienogest Tablets 2mg be used in clinical settings?
A: No. This product is strictly for research use only and not approved for therapeutic or diagnostic use in humans or animals.
Q2: What are common laboratory applications of Dienogest 2mg tablets (Changyining)?
A: They are widely used in hormone modulation, endometriosis modeling, and reproductive endocrinology research.
Q3: Is a COA or SDS available for Changyining Dienogest Tablets?
A: Yes. We provide Certificates of Analysis (COA) and Safety Data Sheets (SDS) upon request for qualified research institutions.
Q4: How should the product be stored and handled?
A: Store below 25°C, protect from light and moisture. Handle using standard laboratory protective equipment (PPE).
Q5: Is there any difference between Changyining Dienogest Tablets and other 2mg dienogest brands for lab research?
A: The active ingredient is the same, but formulation and excipients may vary. Always reference Changyining Dienogest 2mg/28 tablets when replicating or comparing experimental data.
Related products
Recombinant FSH Injection Gonal-F 450 IU (Follitropin Alfa) – Pre-filled Pen
Gonal-F (Follitropin Alfa) is a recombinant human follicle-stimulating hormone (r-hFSH) designed for laboratory-based reproductive and endocrine studies. This product comes in a 33?g (450 IU) pre-filled injection pen and is manufactured by Merck Serono S.p.A., Italy.
Approved under NMPA SJ20160040, Gonal-F is widely used in ovarian stimulation research, hormone response modeling, and in vitro fertilization (IVF) protocol simulation.?? Strictly for research use only. Not intended for human or veterinary treatment.
$1.00Nonoxynol?9 Suppositories 100?mg ×?8 (Biqing?Song®)
Nonoxynol?9 Suppositories (Biqing?Song) deliver 100?mg of nonoxynol?9 per unit, suitable for laboratory-based spermicide and membrane disruption research. This product is for non-clinical, non-therapeutic use.
? Available for wholesale and retail.?Please consult staff for other specifications and uses? $2.00Human Interferon ?2b Vaginal Suppository 500,000 IU × 4 (Shuang Yin Jie / Changchun Institute)
Human Interferon ?2b Vaginal Suppository (Shuang Yin Jie) is a 500,000 IU recombinant interferon product for gynecological research. Each box contains 4 suppositories. Manufactured by Changchun Institute of Biological Products under NMPA approval S20100006.
?? For laboratory research use only. Not for clinical or diagnostic use.
$1.00Triptorelin Acetate Injection 0.1?mg/mL – 7 Pre-filled Syringes (Decapeptyl®)Wholesale price comparison
Decapeptyl® (Triptorelin Acetate Injection) delivers 100?µg triptorelin per 1?mL pre-filled syringe, packaged in sets of 7. Manufactured by Ferring GmbH, this GnRH agonist is ideal for lab-based research on hormone regulation, IVF protocols, prostate cancer, and endometriosis models.?? For laboratory research use only. Not for diagnostic, clinical, or veterinary applications.?Please consult staff for other specifications and uses?
$1.00
Reviews
There are no reviews yet.